Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

NCT00251381 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Oropharyngeal Neoplasms

Interventions

DRUG: Cetuximab

Sponsor

Trial Form Support S.L.

Collaborators

[object Object]